POLR2J4, along with the other dysregulated lncRNAs, could predict the overall survival and recurrence-free survival in HCC patients.13,14,23 An upregulation of POLR2J4 has been observed in both HBV–HCC tissues and cells. This evidence concerns the gene POLR2J4 and hepatocellular carcinoma.